These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9303359)

  • 21. New cachexic factors.
    Tisdale MJ
    Curr Opin Clin Nutr Metab Care; 1998 May; 1(3):253-6. PubMed ID: 10565357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.
    Matsumoto T; Fujimoto-Ouchi K; Tamura S; Tanaka Y; Ishitsuka H
    Br J Cancer; 1999 Feb; 79(5-6):764-9. PubMed ID: 10070867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.
    Beck SA; Tisdale MJ
    Br J Cancer; 1990 Sep; 62(3):420-4. PubMed ID: 2206950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
    Asp ML; Tian M; Wendel AA; Belury MA
    Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation, characterization, and distribution of a 24-kDa proteoglycan in the urine of cachectic cancer and AIDS patients.
    Figueroa JE; Vijayagopal P; Prasad A; Schapira DV; Prasad C
    Biochem Biophys Res Commun; 1999 Jan; 254(3):642-6. PubMed ID: 9920793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host.
    Beck SA; Tisdale MJ
    Cancer Res; 1987 Nov; 47(22):5919-23. PubMed ID: 3311359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine.
    Kanzaki M; Soda K; Gin PT; Kai T; Konishi F; Kawakami M
    Cytokine; 2005 Dec; 32(5):234-9. PubMed ID: 16338141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia.
    Smith KL; Tisdale MJ
    Br J Cancer; 1993 Apr; 67(4):680-5. PubMed ID: 8471425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor protein function in skeletal abdominal muscle of cachectic cancer patients.
    Taskin S; Stumpf VI; Bachmann J; Weber C; Martignoni ME; Friedrich O
    J Cell Mol Med; 2014 Jan; 18(1):69-79. PubMed ID: 24251822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments.
    Hatakeyama S; Summermatter S; Jourdain M; Melly S; Minetti GC; Lach-Trifilieff E
    Skelet Muscle; 2016; 6():26. PubMed ID: 27462398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of a tumor lipid-mobilizing factor.
    Todorov PT; McDevitt TM; Meyer DJ; Ueyama H; Ohkubo I; Tisdale MJ
    Cancer Res; 1998 Jun; 58(11):2353-8. PubMed ID: 9622074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac alterations in cancer-induced cachexia in mice.
    Tian M; Nishijima Y; Asp ML; Stout MB; Reiser PJ; Belury MA
    Int J Oncol; 2010 Aug; 37(2):347-53. PubMed ID: 20596662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.
    Wolf I; Sadetzki S; Kanety H; Kundel Y; Pariente C; Epstein N; Oberman B; Catane R; Kaufman B; Shimon I
    Cancer; 2006 Feb; 106(4):966-73. PubMed ID: 16411208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
    Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
    BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia.
    Simons JP; Schols AM; Westerterp KR; ten Velde GP; Wouters EF
    Am J Clin Nutr; 1995 Apr; 61(4):741-5. PubMed ID: 7702014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).
    Todorov PT; Field WN; Tisdale MJ
    Br J Cancer; 1999 Aug; 80(11):1734-7. PubMed ID: 10468289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of cancer cachexia.
    Tisdale MJ
    J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of weight loss and tumour size in a cachexia model by a high fat diet.
    Tisdale MJ; Brennan RA; Fearon KC
    Br J Cancer; 1987 Jul; 56(1):39-43. PubMed ID: 3620317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.